+Search query
-Structure paper
Title | Improving metabolic stability and removing aldehyde oxidase liability in a 5-azaquinazoline series of IRAK4 inhibitors. |
---|---|
Journal, issue, pages | Bioorg. Med. Chem., Vol. 28, Page 115815-115815, Year 2020 |
Publish date | Nov 21, 2019 (structure data deposition date) |
Authors | Degorce, S.L. / Aagaard, A. / Anjum, R. / Cumming, I.A. / Diene, C.R. / Fallan, C. / Johnson, T. / Leuchowius, K.J. / Orton, A.L. / Pearson, S. ...Degorce, S.L. / Aagaard, A. / Anjum, R. / Cumming, I.A. / Diene, C.R. / Fallan, C. / Johnson, T. / Leuchowius, K.J. / Orton, A.L. / Pearson, S. / Robb, G.R. / Rosen, A. / Scarfe, G.B. / Scott, J.S. / Smith, J.M. / Steward, O.R. / Terstiege, I. / Tucker, M.J. / Turner, P. / Wilkinson, S.D. / Wrigley, G.L. / Xue, Y. |
External links | Bioorg. Med. Chem. / PubMed:33091850 |
Methods | X-ray diffraction |
Resolution | 1.99 - 2.52 Å |
Structure data | PDB-6thw: PDB-6thx: PDB-6thz: PDB-6ti8: PDB-6tia: |
Chemicals | ChemComp-NBK: ChemComp-HOH: ChemComp-N9Z: ChemComp-NB5: ChemComp-NBW: ChemComp-ND2: |
Source |
|
Keywords | SIGNALING PROTEIN / IRAK4 / kinase / inhibitor / cancer |